Distinct cholecystokinin receptors in brain and pancreas.
AUTOR(ES)
Innis, R B
RESUMO
125I-Labeled (Bolton-Hunter) cholecystokinin triacontatriapeptide (CCK-33) binds saturably and reversibly to distinct receptors in brain and pancreatic membranes. The peptide specificity of pancreatic CCK binding is the same as that for pancreatic amylase release. In brain, gastrin and pentagastrin display nanomolar affinity for binding sites, whereas in pancreas these two peptides are virtually inactive. Though these differences indicate that brain and pancreas possess distinct CCK receptors, the two tissues show some similarities. Both pancreas and brain receptors show greater sensitivity to sulfated than to desulfated COOH-terminal octapeptide of CCK and display dissociation constants of 0.3-9.5 nM. The pancreas possesses about 300 times more binding sites than does brain. CCK binding in both brain and pancreas is enhanced by divalent cations and reduced by monovalent cations. Receptor binding in both tissues is regulated in a selective fashion by guanyl nucleotides.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=350402Documentos Relacionados
- Evidence for a common evolutionary origin of brain and pancreas cholecystokinin receptors.
- Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
- Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas.
- Expression of peptide receptors in human endocrine tumours of the pancreas.
- Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.
